Our commitments A new view of care

This press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding a five-year collaboration with Microsoft to transform Kenvue’s digital operations. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of how old do you have to be to start investing similar meaning. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projections of Kenvue and its affiliates. Cautions Concerning Forward-Looking StatementsThis press release contains “forward-looking statements” as defined in the Private Securities Litigation Reform Act of 1995 regarding future operating and financial performance. Forward-looking statements may be identified by the use of words such as “plans,” “expects,” “will,” “anticipates,” “estimates” and other words of similar meaning.

• About Johnson & JohnsonAt Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.
• Built on more than a century of heritage, our iconic brands, including Aveeno®, BAND-AID® Brand, Johnson’s®, Listerine®, Neutrogena® and Tylenol®, are science-backed and recommended by healthcare professionals around the world.
• Current estimates suggest that Kenvue has a brand loyalty rate of approximately 75% among its key products, which is a crucial driver for repeat sales.
• The company’s mission statement focuses on empowering people to live their best lives through innovative personal care and health products.
• We believe everyday care can not only make people well, it can make them whole.

Band-Aid Brand

• Kenvue is a compact yet powerful name that stands for the fusion of knowledge and vision.
• “Ken” is an English word meaning “to know,” and “vue” is French, referring to insight.
• Our new home was designed with sustainability in mind and fosters connections and wellness.
• The company aims to leverage its established brands in the consumer health space, which includes products like Tylenol, Listerine, and Neutrogena.
• Our committed collaboration fuels our relentless external competitive drive — because the stronger our bonds are, the stronger our brands are, too.

According to market analysis, nearly 40% of Kenvue’s sales were derived from e-commerce channels in 2023. As of September 2023, Kenvue continued to see positive momentum in its stock performance, with shares trading around $25.30, marking a year-to-date increase of over 15%. By the end of its first trading day on May 19, 2023, Kenvue’s stock rose to $24.21, reflecting an increase of 10% from its IPO price, giving the company a market capitalization of approximately $41 billion. You should view the News section and the most recent SEC Filings in the Investor section in order to receive the most current information made available by Johnson & Johnson Services, Inc. Kenvue’s purpose, Realize the Extraordinary Power of Everyday Care, will guide the company’s actions and long-term aspirations, from strategy to talent philosophy, and more.

We put people first, we care fiercely, we earn trust with science and we solve with courage to deliver the best possible care. No part of this website, including text, graphics, logos, images, and software, may be reproduced, distributed, or transmitted in any form or by any means without the prior written permission of Paxton Media Ltd. Johnson & Johnson’s Consumer Health segment reported a revenue of $14.6 billion in the Full-Year 2021. It is projected that, following the separation, Kenvue will generate sales in over 100 countries. Johnson & Johnson’s Kenvue – previously the planned New Consumer Health Company – is just one part of the 135-year old company’s plan to reinvigorate its corporate image.

Full details of the results are available in a separate press release issued this morning by Johnson & Johnson. The importance of fx choice review biosimilars only continues to grow, driven by the potential savings they are able to deliver to healthcare systems. On May 18, 2023, Kenvue priced its IPO at $22 per share, raising approximately $3.8 billion.

Nurture healthy people

Kenvue’s dedication to research and development underscores its mission, with a reported investment of approximately $1.5 billion in R&D for the fiscal year 2023. The company’s portfolio includes over 20 brands and aims to expand its product offering in wellness and personal care segments. Kenvue is strategically positioning itself to leverage market trends toward e-commerce and direct-to-consumer channels, which saw a surge during the pandemic. About Johnson & JohnsonAt Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress.

This partnership builds upon Kenvue’s pilots that integrate Azure AI, Copilot Studio and 365 Copilot to create efficiencies across supply chain, operations and content creation. The predictive analytics and AI-driven upgrades will help Kenvue expand these efforts. “The new logo centres on the ‘K’ symbol, embodying the company’s strengths – the geometry of the rectangle representing scientific precision and the round edges evoking the warmth of care,” the press release stated. All content is of a general nature and may not address the specific circumstances of any individual or entity. Any actions you take based on the information provided here are strictly at your own risk. You accept full responsibility for any decisions or outcomes arising from your use of this website and agree to release us from any liability in connection with your use of, or reliance upon, the content or products found herein.

Millions and millions of lives touched every day

Here, the double-height, light-flooded space is filled with ample (and different types of) seating to meet and dine. Main Street also serves as the building’s connector to all “neighborhoods” and their amenities. Along Main Street is also The Store, which allows visitors and employees to purchase their favorite Kenvue products.

An Insights Lab, a high tech, multi-room experience, is designed to transform how Kenvue develops, tests, and showcases its products. Understanding how to harness real-world data and digital insights is essential. The overall financial health of Kenvue is also evidenced by its operating income, which stood at approximately $3.3 billion for the fiscal year 2022, translating to an operating margin of 25%. This reflects effective cost controls and strong product demand in a competitive market. Kenvue leverages direct-to-consumer (DTC) strategies, bolstering its online presence to enhance customer engagement.

As of October 2023, Kenvue has initiated several initiatives to enhance sustainability and reduce environmental impact. The company has committed to reducing its carbon footprint by 50% by 2030, focusing on sustainable packaging solutions and responsible sourcing practices. Looking at the competitive landscape, Kenvue holds a strong position in the consumer health market, which was valued at approximately $445 billion in 2022, and is expected to grow at a CAGR of 4.5% from 2023 to 2030. Company leadership tapped Lippincott as their dedicated naming specialist with global expertise, and we embarked on a nine-month journey to create a name that would resonate with more than 20,000 employees and billions of consumers worldwide. The Consumer Health segment generated revenue of $14.6 billion in Full-Year 2021 and, following the planned separation, Kenvue would generate sales in over 100 countries, driven by world-class innovation capabilities and demonstrated business momentum.

Kenvue appoints Andrew Stanleick, president of Skin Health & Beauty, North America and Europe, Middle East and Africa

Trusted Johnson & Johnson brands including Tylenol, Aveeno, Neutrogena, Listerine, and Band-Aid are set to fall under the new, independent company name in a next-chapter move of repurposing and modernisation. Kenvue also focuses on innovation and product development, launching new products that cater to emerging consumer needs. In 2022, Kenvue introduced over 30 new products across various categories, resulting in a projected incremental revenue of approximately $500 million for 2023. Kenvue Inc., a spin-off from Johnson & Johnson, became publicly traded on May 4, 2023, under the ticker symbol “KVUE”. nasdaq holidays 2021 The ownership of Kenvue is a critical aspect of its corporate structure as it dictates board influence, strategic direction, and financial performance. The Essential Health segment offers oral and baby, women’s health, wound, and other care products under the Listerine, Johnson’s, Band-Aid, and Stayfree, o.b., tampons, Carefree, and Desitin Diaper Rash brands.

Relief within reach: 5 pain care options from Kenvue brands

But beyond our portfolio of iconic brands, Kenvue is built on a foundation of core values, which fuel our 20,000+ global team members every day. “We believe that daily self-care rituals add up over time and have a profound cumulative impact on your wellbeing. And our work is to put that power into the hands of consumers around the world,” Mongon asserted. Kenvue’s strategy includes robust investment in research and development (R&D), amounting to approximately $500 million in 2023.

International markets have become a significant growth avenue, with revenues from outside the U.S. contributing around 30% to total sales. Emerging markets such as Asia and Latin America have been highlighted as strategic growth areas, reflecting a year-over-year growth rate of approximately 10% in those regions. Kenvue aims to achieve a net-zero emissions target across its global operations by 2030 and continues to implement initiatives that support this goal. In 2022, Kenvue reported a reduction in greenhouse gas emissions by 20% as part of its commitment to environmental responsibility.

The company’s mission statement resonates with its corporate social responsibility initiatives, where they have invested over $200 million in community health programs since their inception. Our new home was designed with sustainability in mind and fosters connections and wellness. The building itself is LEED Gold certified, designed to use fewer resources, create less waste and respect the local habitat. Aligned with our Healthy Lives Mission and commitment to reduce our environmental footprint, the new Global Headquarters in Summit reflects our company’s commitment to a healthy planet. Right past the lobby, Kenvuers and visitors will find Main Street, which is the heart of the building.

Kenvue Inc., a subsidiary formed from Johnson & Johnson’s consumer health division, generates revenue primarily through a diverse portfolio of consumer healthcare products. As of the latest financial reports, Kenvue offers an array of products, including over-the-counter medications, skincare, and personal care items. Notable brands under Kenvue include Tylenol, Band-Aid, Neutrogena, and Aveeno, contributing significantly to its revenue stream. If you’ve heard of Kenvue, you may already know that we’re a global consumer health company.

That’s why our Global Headquarters is specially designed to be a place where Kenvuers can do more than just work. Various amenities include a coffee shop, a fitness center, a health clinic, a nursing room, an interfaith room, and a mindspace room to ensure physical and mental well-being. The start of 2025 marks the beginning of a new chapter at Kenvue — our move to a new Global Headquarters in Summit, New Jersey.